Susan Peock

7.1k total citations
12 papers, 645 citations indexed

About

Susan Peock is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Susan Peock has authored 12 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Susan Peock's work include BRCA gene mutations in cancer (9 papers), Nutrition, Genetics, and Disease (2 papers) and Cancer Risks and Factors (2 papers). Susan Peock is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Nutrition, Genetics, and Disease (2 papers) and Cancer Risks and Factors (2 papers). Susan Peock collaborates with scholars based in United Kingdom, United States and Australia. Susan Peock's co-authors include Douglas F. Easton, Antonis C. Antoniou, Nadine Andrieu, Matti A. Rookus, Jenny Chang‐Claude, Richard M. Brohet, Catherine Noguès, D. Gareth Evans, David E. Goldgar and Rosalind A. Eeles and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Susan Peock

12 papers receiving 626 citations

Peers

Susan Peock
G Thomas United Kingdom
DF Easton United Kingdom
Mary Daly United States
Kerry Kingham United States
Brigette Tippin Davis United States
Lyssa Friedman United States
Susan Peock
Citations per year, relative to Susan Peock Susan Peock (= 1×) peers Agnès Hardouin

Countries citing papers authored by Susan Peock

Since Specialization
Citations

This map shows the geographic impact of Susan Peock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Peock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Peock more than expected).

Fields of papers citing papers by Susan Peock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Peock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Peock. The network helps show where Susan Peock may publish in the future.

Co-authorship network of co-authors of Susan Peock

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Peock. A scholar is included among the top collaborators of Susan Peock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Peock. Susan Peock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Castro, Elena, David Olmos, Chee Goh, et al.. (2013). Effect of germ-line BRCA mutations in biochemical relapse and survival after treatment for localized prostate cancer.. Journal of Clinical Oncology. 31(6_suppl). 29–29. 2 indexed citations
2.
Castro, Elena, David Olmos, Chee Goh, et al.. (2012). BRCA carrier status as an independent prognostic factor associated with earlier biochemical relapse in local prostate cancer.. Journal of Clinical Oncology. 30(15_suppl). 1545–1545. 1 indexed citations
3.
Spurdle, Amanda B., Paul Fahey, Xiaohong Chen, et al.. (2009). Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 122(1). 281–285. 7 indexed citations
4.
Mitra, Anita, Charles Jameson, Yolanda Barbáchano, et al.. (2009). Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology. 55(6). 696–704. 81 indexed citations
5.
Spurdle, Amanda B., Andrew J. Deans, David L. Duffy, et al.. (2008). No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 115(2). 307–313. 9 indexed citations
6.
Ramus, Susan J., Patricia Harrington, Susan Peock, et al.. (2007). Screening for theBRCA1-ins6kbEx13mutation: potential for misdiagnosis. Human Mutation. 28(5). 525–526. 7 indexed citations
7.
Brohet, Richard M., Douglas F. Easton, Antonis C. Antoniou, et al.. (2007). Oral Contraceptives and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study: A Report From EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. Journal of Clinical Oncology. 25(25). 3831–3836. 96 indexed citations
8.
Chang‐Claude, Jenny, Nadine Andrieu, Matti A. Rookus, et al.. (2007). Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 16(4). 740–746. 55 indexed citations
9.
Andrieu, Nadine, David E. Goldgar, Douglas F. Easton, et al.. (2006). Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). JNCI Journal of the National Cancer Institute. 98(8). 535–544. 136 indexed citations
10.
Mitchell, Gillian, Antonis C. Antoniou, Ruth Warren, et al.. (2006). Mammographic Density and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Research. 66(3). 1866–1872. 90 indexed citations
11.
Andrieu, Nadine, Douglas F. Easton, Jenny Chang‐Claude, et al.. (2006). Effect of Chest X-Rays on the Risk of Breast Cancer Among BRCA1/2 Mutation Carriers in the International BRCA1/2 Carrier Cohort Study: A Report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group. Journal of Clinical Oncology. 24(21). 3361–3366. 121 indexed citations
12.
Spurdle, Amanda B., Antonis C. Antoniou, David L. Duffy, et al.. (2004). The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research. 7(2). R176–83. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026